May 2026
The global computational medicine and drug discovery software market size was evaluated at USD 10.90 billion in 2025 and is predicted to hit around USD 60.52 billion by 2035, growing at a CAGR of 18.70%.
December 2025
The global pharmacovigilance and drug safety software market size was evaluated at USD 2.09 billion in 2025 and is predicted to hit around USD 5.06 billion by 2035, growing at a CAGR of 9.24%.
June 2026
The global CNS drug discovery market size was evaluated at USD 9.80 billion in 2025 and is predicted to hit around USD 27.55 billion by 2035, growing at a CAGR of 10.90%.
June 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
June 2026
The US drug discovery market size was evaluated at USD 26.24 billion in 2025 and is predicted to hit around USD 63.02 billion by 2035, growing at a CAGR of 9.16%.
May 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
April 2026
The global drug discovery informatics market size is estimated at USD 4.81 billion in 2025 and is projected to surpass around USD 13.68 billion by 2035 at a CAGR of 11.02%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
November 2025
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 6.93 billion in 2025 with a solid CAGR of 9.90%.
November 2025
The global nuclear medicine software market size is estimated to hit around USD 2164.70 million by 2034 increasing from USD 978.76 million in 2025, with a CAGR of 9.22%.
September 2025
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
January 2025
The drug discovery services market size was estimated at USD 21.26 billion in 2024 and is expected to hit around USD 79.71 billion by 2034, growing at a CAGR of 14.13% from 2025 to 2034.
January 2025
The global drug discovery outsourcing market size was valued at USD 4.15 billion in 2024 and is projected to hit around USD 8.43 billion by 2034 with a CAGR of 7.34%.
August 2025
The global pulmonary alveolar proteinosis (PAP) drugs market size was evaluated at USD 750.05 million in 2024 and is predicted to hit around USD 1,478.22 million by 2034, growing at a CAGR of 7.02%.
July 2025
The global 3D printed drugs market size was estimated at USD 338.28 million in 2024 and is predicted to reach around USD 789.20 million by 2034 with a CAGR of 8.84%.
June 2026
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
June 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 792.67 million in 2025, with a CAGR of 9.00%.
May 2026
The global pharmacy inventory management software solutions and cabinet market size is estimated to hit around USD 15.23 billion by 2035 from USD 7.15 billion in 2025, at a CAGR of 7.85%.
May 2026
The global project and portfolio management software market size was evaluated at USD 6.90 billion in 2025 and is predicted to hit around USD 18.22 billion by 2035, growing at a CAGR of 10.20%.
May 2026
The global CAD and PLM software market size was evaluated at USD 19.01 billion in 2025 and is predicted to hit around USD 42.27 billion by 2035, growing at a CAGR of 8.32%.
May 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 1.86 billion in 2025 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
May 2026
The global medical, legal, and regulatory (MLR) review software market size was evaluated at USD 17.09 billion in 2025 and is predicted to hit around USD 42.42 billion by 2035, growing at a CAGR of 9.52%.
April 2026
The global medical device vigilance and patient safety software market size was evaluated at USD 1.40 billion in 2025 and is predicted to hit around USD 4.23 billion by 2035, growing at a CAGR of 11.70%.
April 2026
The contraceptive drugs and devices market size reached USD 33.26 billion in 2025 and is projected to surpass around USD 58.87 billion by 2035, with a notable CAGR of 5.88%.
March 2026
The global asthma and COPD drugs market size is expected to increase from USD 43.49 billion in 2025 to hit around USD 92.39 billion by 2035, with a CAGR of 7.83%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com